Skip to main content
. Author manuscript; available in PMC: 2018 Jun 29.
Published in final edited form as: J Biopharm Stat. 2017 Oct 6;28(3):562–574. doi: 10.1080/10543406.2017.1372774

Table 4.

Operating Characteristics comparing the three response models using continuous doses

True MTD
−0.16 0.52 1.22
Response ρ0 (B) Logistic (A) (D) Logistic (C) (F) Logistic (E)
Safety Average % DLTs 45.000 45.900 47.800 33.600 34.100 33.500 28.200 28.200 26.600
% trials w. DLT rate > θ + 0.1 72.1 79.0 89.2 4.0 4.7 6.9 0.3 0.1 0.1
Efficiency Average MTD −0.018 −0.058 −0.116 0.519 0.519 0.556 1.211 1.212 1.1246
Average bias 0.139 0.099 0.041 −0.001 −0.001 0.036 −0.005 −0.004 −0.091
RMSE 0.225 0.128 0.064 0.082 0.105 0.199 0.122 0.150 0.307
% trials: MTD estimate is in (γ − 0.10, γ + 0.10) 42.1 56.7 87.3 78.9 66.3 37.6 62.0 49.4 16.9
(γ − 0.15, γ + 0.15) 56.6 72.9 96.7 93.1 84.8 55.4 77.6 67.2 24.7
(γ − 0.15γ, γ + 0.15γ) 7.9 16.3 35.3 66.8 55.0 29.0 85.7 74.5 28.6
(γ − 0.20γ, γ + 0.20γ) 10.7 21.0 45.4 81.2 68.5 39.4 94.3 87.8 46.9